Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-017229
Filing Date
2010-03-31
Accepted
2010-03-31 13:51:21
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v179442_10k.htm 10-K 1841073
2 v179442_ex23-1.htm EX-23.1 2965
3 v179442_ex31-1.htm EX-31.1 16926
4 v179442_ex31-2.htm EX-31.2 17348
5 v179442_ex32-1.htm EX-32.1 6721
6 v179442_ex32-2.htm EX-32.2 6821
7 v179442_ex99-1.htm EX-99.1 165892
8 v179442_ex99-2.htm EX-99.2 855425
  Complete submission text file 0001144204-10-017229.txt   2914814
Mailing Address 100 SOUTH MAIN STREET SUITE 300 DOYLESTOWN PA 18901
Business Address 100 SOUTH MAIN STREET SUITE 300 DOYLESTOWN PA 18901 267-880-1595
QUANTRX BIOMEDICAL CORP (Filer) CIK: 0000820608 (see all company filings)

EIN.: 330202574 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17119 | Film No.: 10717934
SIC: 3841 Surgical & Medical Instruments & Apparatus